Peptide database

An investigational triple agonist peptide acting at the GIP, GLP-1 and glucagon receptors. It is one of the most closely watched compounds in metabolic research because of the magnitude of body-weight change reported in published phase 2 trials.

A dual GIP and GLP-1 receptor agonist that has been evaluated across a large published clinical programme in type 2 diabetes and in weight management, with well-characterised pharmacokinetics and a documented stepwise escalation schedule.

A synthetic pentadecapeptide derived from a sequence identified in human gastric juice. It is one of the most widely studied peptides in preclinical tissue-repair research, though human clinical data remains very limited.

A synthetic fragment related to thymosin beta-4, a naturally occurring actin-sequestering protein. Research focuses on cell migration, angiogenesis and soft-tissue repair, with a substantial veterinary literature.

A 16-amino-acid mitochondrial-derived peptide encoded in mitochondrial DNA. Research interest centres on metabolic regulation, exercise physiology and biological ageing.

A tripeptide corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone. It is studied for anti-inflammatory activity without the pigmentation effects associated with the parent hormone.

A coenzyme present in every living cell and central to energy metabolism and DNA repair. Although not a peptide, NAD+ appears throughout longevity research and is commonly catalogued alongside research peptides.

A tripeptide antioxidant synthesised in every cell, central to redox balance and detoxification. It is one of the most extensively characterised endogenous peptides in biochemistry.

A naturally occurring copper-binding tripeptide found in human plasma. It is among the best characterised peptides in dermatological and wound-healing research.

A mitochondria-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane. It has progressed further into human clinical evaluation than most research peptides in the longevity space.

A synthetic heptapeptide derived from the immune peptide tuftsin, developed in Russia and studied predominantly in anxiety, stress-response and cognitive models. It is most often described in the literature as an anxiolytic-type research peptide without sedative properties.

A synthetic heptapeptide based on the ACTH(4-10) fragment with a Pro-Gly-Pro extension. It is studied primarily in neuroprotection, ischaemic stroke recovery and attention or memory endpoints, and carries no corticotropic hormonal activity.

A nonapeptide first isolated from rabbit cerebral venous blood during induced slow-wave sleep. It is studied in sleep architecture, stress-response and endocrine regulation models, and its physiological role remains incompletely characterised.

A nine-amino-acid neurohypophysial hormone produced in the hypothalamus and released from the posterior pituitary. It is one of the best-characterised peptides in this database, with an established clinical role in obstetrics and an extensive research literature in social and behavioural neuroscience.

A water-soluble cobalt-containing vitamin, not a peptide, but included because it is frequently used as a diluent-compatible companion compound and appears widely in research contexts alongside peptides. It is an essential cofactor for methylation and mitochondrial metabolism.

A copper-binding tripeptide closely related to GHK-Cu, distinguished in the literature by a research focus on hair-follicle biology and dermal microvasculature rather than general skin remodelling.

A compounded multi-peptide blend rather than a single molecule, combining KPV, larazotide, GHK-Cu, BPC-157 and TB-500. It has no independent research base of its own — the evidence available applies to each constituent studied separately.